SUMMARY A questionnaire was prepared under the auspices of the Department of Health with the aim of defining the extent and nature of immunocytochemistry use within pathology departments. The questionnaire was circulated to 320 pathology laboratories within the United Kingdom, and a total of 178 replies were received, representing a response rate of 56%. One hundred and thirty eight (78%) of the respondents used immunocytochemical techniques: 64 used immunocytochemical kits, including 35 district general hospital and 29 teaching hospital laboratories. An extensive range of antibodies was being used on a variety of tissues, epithelial and lymphoid markers far exceeding all other antibodies. Several differences in the numbers of cases and the types of tissues studied were identified among laboratories. The techniques used, the problems encountered, and the procedures followed with unsatisfactory reagents were also analysed. Finally, an assessment of the resources allocated to immunocytochemistry, both in terms of staff and reagent costs was made. Taking into account the response rate of 56% and the uncertainty that all pathology departments in the United Kingdom had been circulated, the estimated annual total costs for immunocytochemistry for all pathology laboratories in the United Kingdom was £5-4 million.
The use of immunocytochemical techniques has become widespread in the United Kingdom, but few data are available on exactly how and to what extent these techniques are used. A questionnaire circulated to district general hospital laboratories in 1986 indicated that 7017% of these laboratories were using immunocytochemistry in routine diagnostic practice,' but no comparable data are available for teaching hospital laboratories.
A questionnaire was prepared by two ofthe authors (EH, IL) with the aim of defining the extent of use of immunocytochemistry within pathology departments in the United Kingdom, the type and range of tests being performed, the techniques being used, the problems associated with immunocytochemistry and the extent of kit use were analysed. Differences between methods of use in laboratories in district Accepted for publication 25 May 1989 general hospitals and teaching hospitals were also defined. An assessment of the associated staff and reagent costs was used to provide an estimated total cost for all pathology departments in the United Kingdom.
Methods
The questionnaire (copy available on request) was circulated to a total of 320 pathology laboratories throughout the United Kingdom using a list of histopathologists and immunopathologists provided by the Royal College of Pathologists. Information sought included types of antibodies used, types of tissues studied, and numbers of cases analysed. The extent of kit use, the commercial suppliers used, and technical details involved in immunocytochemistry were also requested. The results were collated, entered into a computerised database, and analysed statistically. 1012
Antibody usage questionnaire Percentage calculated from number of laboratories/total number of respondents (n = 178).
tPercentage calculated from number of laboratories using kits/total number of respondents (n= 178).
tPercentage calculated from number of laboratories using kits/total number of immunocytochemistry using laboratories (n = 138).
Results
Of the 320 laboratories, 178 (56%) replied to the questionnaire, about 70% of which were in district general hospitals and the rest in teaching hospitals (table 1) . The actual proportion of hospital types was slightly different because some hospitals had up to three laboratories actively using immunocytochemical methods as part of the diagnostic service. The proportion of teaching hospital respondents (65%) was higher than the proportion of district general hospital respondents (53%). Table 1 shows the number ofboth hospital laboratory types performing immunocytochemistry, together with the number using immunocytochemical kits. Forty (22%) laboratories reported no use of immunocytochemical techniques, five in teaching hospitals and 35 in district general hospitals. Table 2 shows the types of tissues which had been subjected to immunocytochemical analysis, the number of cases studied, and the mean number of antibodies used to study each case during a single month. Although there were almost twice as many district general hospital laboratories as teaching hospital laboratories using immunocytochemistry, the number ofcases was much higher in teaching hospitals 1013 for all tissue types studied. Analysis of lymphoid and epithelial samples far exceeded that of other tissues in both hospital laboratory types. Lymph node analysis was performed more frequently than analysis of other tissues in teaching hospital laboratories, but in district general hospital laboratories analysis of epithelial tissues predominated. The mean number ofantibodies for each case was consistently higher in teaching hospital laboratories than in district general hospital laboratories.
The companies supplying antibodies to the 138 laboratories using immunocytochemistry are listed in table 3. Dako supplied almost all the laboratories using immunocytochemistry; among the other suppliers only Becton Dickinson exceeded 50%. Ortho supplied only 16% of laboratories with primary antibodies, whereas they supplied 46 (32%) of laboratories using kits (table 4). When asked to recommend a particular manufacturer, 93 (67%) of the immunocytochemistry laboratories suggested Dako, with much smaller numbers recommending Becton Dickinson, Eurodiagnostics, or other companies. Table 5 lists the primary antibodies used by the laboratories in order ofgreatest use, and illustrates the very wide range of antibodies being used. Not surprisingly, in view of the fact that lymph node analysis was frequently performed by both hospital types, The number of different kits used for each laboratory varied between one and nine, with most laboratories using just one or two types of kit. Table 4 shows that Dako supplied 57 (40%) and Ortho 46 (32%) of the kits used. Between them, Dako and Ortho supplied 45 (70%) of the laboratories with at least one kit. One hundred and forty two different types of kits were used, and these could be divided into two broad groups. The first and largest group (n = 100) comprised those kits which include one or more primary antibodies such as prostatic acid phosphatase and hepatitis B surface antigen. The second group (n = 42) were kits for one technique only which did not include a primary antibody-for example, ABComplex HRP (Dako k355), Universal PAP kit. Table 7 shows the range ofkits used by the laboratories in the first group. A wide range of antibodies was being used in kit form, Table 10 shows that both reagent and staff costs were considerably higher in teaching hospital than in district general hospital laboratories, and the total cost of immunocytochemistry in teaching hospital laboratories was about twice that in district general hospital laboratories. A small number of the laboratories were unable or unwilling to supply detailed figures for reagent costs, and an estimate has been made for those missing values using the mean values derived from those laboratories (n= 131) who did provide detailed figures. The final estimate oflikely total expenditure in the United Kingdom was again based on the mean values for staffand reagent costs to provide an estimate of expenditure for a total of 320 laboratories (240 district general hospital and 80 teaching hospital laboratories). Teaching hospitals).
Assuming that the average laboratory buys one kit ofeach type a year, the percentage of the total amount spent on immunocytochemical reagents a year can be estimated. Laboratories in teaching hospitals used an average of 8% of the total amount spent on immunocytochemical reagents to buy kits; the corresponding figure for laboratories in district general hospitals was 28%. In district general hospital laboratories 75% of the total amount spent on kits was used to buy complete kits-that is, those in which a primary antibody is included; in teaching hospital laboratories this proportion was lower (60%).
Discussion
Responses from the 178 laboratories indicated that about 70% of district general hospital laboratories were using immunocytochemistry, while for teaching hospital laboratories this figure was 90%. The small number ofteaching hospital laboratories not performing immunocytochemistry can be explained by the inclusion of some specialised departments such as forensic and ophthalmology laboratories. All of the teaching hospital laboratories that were not highly specialised were using immunocytochemical techniques routinely. Among those district general hospital laboratories not performing immunocytochemistry at the time the questionnaire was circulated, many indicated that they would either be setting up these techniques in the near future, or that they would like to see immunocytochemistry techniques established within their laboratories, provided that adequate resources could be obtained.
Teaching hospital laboratories performed Angel, Heyderman, Lauder immunocytochemical tests on a much higher number ofcases than district general hospital laboratories, and the mean number of antibodies used to analyse each case was consistently higher in teaching hospital laboratories than in district general hospital laboratories. In teaching hospital laboratories lymph node analysis exceeded that of other tissues by far, while although lymph node analysis was frequently performed in district general hospital laboratories, epithelial tissues were more commonly studied. The larger number of antibodies used for each case in teaching hospital laboratories implies that these laboratories more frequently analysed tissues using panels of antisera. The reasons for these variations between hospital laboratory types are probably complex, and may include factors such as availability of resources and a differing emphasis on research and developmental aspects of immunocytochemistry. Although the questionnaire asked laboratories to estimate the relative proportions of diagnostic and research work performed, some laboratories found this difficult to answer, because they could not clearly separate the diagnostic from the research and developmental applications of their work. From the 126 laboratories able to provide an answer, it was calculated that 92% ofimmunocytochemistry in district general hospital laboratories and 62% in teaching hospital laboratories is diagnostic. This difference may in part account for some of the differences between hospital laboratory types.
A larger proportion of laboratories in teaching hospitals (64%) use kits when compared with laboratories in district general hospitals (38%). Because kits supply reagents pre-diluted and ready to use, it was anticipated that their use would appeal more to smaller laboratories in district general hospitals with relatively less experienced staff. A detailed breakdown ofthe costs involved in kit usage, however, shows that district general hospital laboratories use a much larger proportion of the money they spend on immunocytochemical reagents to buy kits (28%) than teaching hospital laboratories (8%). Differences in the types of kits purchased by the hospital laboratory types were also noted. For example, the Anaplastic Tumour Kit, marketed by Dako, and intended to allow anaplastic tumours to be divided into the two broad groups of carcinoma or lymphoma, was used exclusively by district general hospital laboratories. This may partly reflect the much higher percentage of diagnostic immunocytochemistry done in district general hospital laboratories (92%) in contrast to teaching hospital laboratories (62%). Almost all of the kits detecting hormones were bought by laboratories in teaching hospitals, which again may reflect a higher interest in this field in teaching hospital laboratories. Although lymph node analysis was more frequently
